The potential role of the combined PARP-1 and VEGF inhibition in severe SARS-CoV-2 (COVID-19) infection
Introduction: During the evolution of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, several drug candidates have been proposed for repositioning towards a quest for more effective treatments. Methodology: We reviewed recent literature (Pubmed, Google, Clinicalt...
Saved in:
| Main Authors: | Dimitra Ioanna Lampropoulou, Vanessa Meletia Bala, Eleni Zerva, Evangelia Pliakou, Dimitrios Filippou, Maria Gazouli, Gerasimos Aravantinos |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2022-01-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/15386 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and evaluation of a 99mTc-labeled olaparib analog for PARP imaging
by: Wei Xu, et al.
Published: (2025-07-01) -
The poly (ADP-ribose) polymerase inhibitor olaparib attenuates established pulmonary fibrosis in a large animal model
by: Habtamu B. Derseh, et al.
Published: (2025-08-01) -
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance
by: Li‐Min Wang, et al.
Published: (2023-01-01) -
Synchronous Gastric Adenocarcinoma and Diffuse Large B-Cell Lymphoma in the Pelvis: A Rare Case Presentation
by: Evangelia Pliakou, et al.
Published: (2022-01-01) -
PARP9-PARP13-PARP14 axis tunes colorectal cancer response to radiotherapy
by: Rimvile Prokarenkaite, et al.
Published: (2025-07-01)